Visa Inc. (NYSE:V) Annual Results: Here's What Analysts Are Forecasting For This Year
Last week, you might have seen that Visa Inc. (NYSE:V) released its full-year result to the market. The early response… …read more […]
Last week, you might have seen that Visa Inc. (NYSE:V) released its full-year result to the market. The early response… …read more […]
Boeing is unlikely to launch a new plane in the near future but its options will depend in part on how successfully its grounded 737 MAX regains its position in the market, the head of one of its engine suppliers said on Friday. The MAX is expected to win safety approval within weeks following a 19-month grounding in the wake of two crashes, Safran Chief Executive Philippe Petitcolin said. “We are doing everything with Boeing to put the MAX back in service in the best possible conditions,” he told reporters. …read more […]
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […] …read more […]
Last week saw the newest quarterly earnings release from Teladoc Health, Inc. (NYSE:TDOC), an important milestone in… …read more […]
Markets are down, but not collapsing. Investors remain worried about the coronavirus, and Tuesday’s election remains up in the air. Uncertainty rules the day, exacerbated by recent market losses. Wall Street, however, expects that the bulls will start running again after next week’s results – who wins will be less important than having a result.In the meantime, market declines and low share prices make for a prime time to buy in – if you judge the bottom correctly. Do that, and the rest is just ‘buy low and sell high.’ And to that end, Wall Street’s analysts have been pointing …read more […]
VSBLTY Groupe Tech (OTC: VSBY) (CSE: VSBY) Oct 29, 2020 Investors Discovery Day Livestream ABOUT THE EVENT NEXT SUPER STOCK Live! is Wall Street Reporter’s flagship investor conference series featuring presentations by a select group of […]
CloudMD (OTC: DOCRF) (TSX.V: DOC) NEXT SUPER STOCK livestream presentation October 29, 2020 ABOUT THE EVENT NEXT SUPER STOCK Live! is Wall Street Reporter’s flagship investor conference series featuring presentations by a select group of companies which […]
(Bloomberg) — Chevron Corp. posted a surprise profit as the oil supermajor slashed capital spending to cope with the pandemic-driven collapse in crude demand.The California oil titan posted adjusted per-share earnings of 11 cents for the third quarter, outperforming the average 27-cent loss expected by analysts in a Bloomberg survey. Production from the company’s crude and natural gas wells tumbled to the lowest in more than two years, partly because of intentional decisions to curtail operations that couldn’t turn profits as prices cratered.Things are bad for the industry, Chief Executive Officer Mike Wirth said in a statement, and he provided …read more […]
First Eagle Investment Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. The First Eagle Global Fund A Shares posted a return of 5.64% for the third quarter (without sales charge), underperforming its benchmark, the MSCI World Index which returned 7.93% in the same quarter. You should check […] …read more […]
First Eagle Investment Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. The First Eagle Global Fund A Shares posted a return of 5.64% for the third quarter (without sales charge), underperforming its benchmark, the MSCI World Index which returned 7.93% in the same quarter. You should check […] …read more […]
(Bloomberg) — Biogen Inc.’s big bet that U.S. regulators will approve its experimental drug for Alzheimer’s disease faces a key test next week when a panel of outside advisers reviews results from a pair of studies.The Nov. 6 advisory committee meeting is a highlight of the year for health-care investors and a “major binary event” for the $38 billion drug giant, Stifel analyst Paul Matteis said. Briefing documents, which become public two days before the meeting, are likely to be a “bigger determinant than usual in dictating how panelists eventually vote,” he said.Wall Street analysts have suggested Biogen shares could …read more […]
The Federal Reserve on Friday lowered the minimum loan size on its loans to small and medium-sized businesses, in an effort to drive higher uptake of its Main Street Lending Program. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.